Cargando…

Slow and steady wins the race: Optimizing lentiviral vector production for efficient clinical-scale manufacturing

Detalles Bibliográficos
Autor principal:	McCarron, Alexandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2023
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10480568/ https://www.ncbi.nlm.nih.gov/pubmed/37681060 http://dx.doi.org/10.1016/j.omtm.2023.08.011

Ejemplares similares

Slow but steady wins the drug race
por: Wells, William A.
Publicado: (2004)

Slow and steady wins the race: an examination of bacterial persistence
por: Renbarger, Tara L., et al.
Publicado: (2017)

Large-scale production of lentiviral vectors using multilayer cell factories
por: Rout-Pitt, Nathan, et al.
Publicado: (2018)

Slow and steady wins the race: Spatial and stochastic processes and the failure of suppression gene drives
por: Paril, Jeff F., et al.
Publicado: (2022)

Slow and steady wins the race: Better walking than running. The turtle's lesson in the times of COVID-19
por: Sciomer, S., et al.
Publicado: (2021)

Vancomycin continuous infusion versus intermittent infusion during continuous venovenous hemofiltration: slow and steady may win the race
por: Lin, Hsin, et al.
Publicado: (2015)

Arginine vasopressin versus norepinephrine: will the stronger one win the race?
por: Ertmer, Christian, et al.
Publicado: (2006)

Slow and steady wins the race: The behaviour and welfare of commercial faster growing broiler breeds compared to a commercial slower growing breed
por: Dixon, Laura M.
Publicado: (2020)

Repeat or single-dose lentiviral vector administration to mouse lungs? It’s all about the timing
por: Donnelley, Martin, et al.
Publicado: (2023)

Optimization of lentiviral vector production for scale-up in fixed-bed bioreactor
por: Valkama, A J, et al.
Publicado: (2018)

Toward lentiviral vectors for antiangiogenic ocular gene therapy
por: Askou, Anne Louise, et al.
Publicado: (2023)

Production of lentiviral vectors
por: Merten, Otto-Wilhelm, et al.
Publicado: (2016)

An Optimized Lentiviral Vector Efficiently Corrects the Human Sickle Cell Disease Phenotype
por: Weber, Leslie, et al.
Publicado: (2018)

Large-Scale Production of Lentiviral Vectors: Current Perspectives and Challenges
por: Martínez-Molina, Eduardo, et al.
Publicado: (2020)

Minimal impact of ZAP on lentiviral vector production and transduction efficiency
por: Sertkaya, Helin, et al.
Publicado: (2021)

Optimization of lentiviral vector production using polyethylenimine-mediated transfection
por: TANG, YONG, et al.
Publicado: (2015)

Process intensification for lentiviral vector manufacturing using tangential flow depth filtration
por: Tona, Robert M., et al.
Publicado: (2023)

Single-Dose Lentiviral Mediated Gene Therapy Recovers CFTR Function in Cystic Fibrosis Knockout Rats
por: Reyne, Nicole, et al.
Publicado: (2021)

Development of Large-Scale Downstream Processing for Lentiviral Vectors
por: Valkama, Anniina J., et al.
Publicado: (2020)

Benchmarking of Scale-X Bioreactor System in Lentiviral and Adenoviral Vector Production
por: Leinonen, Hanna M., et al.
Publicado: (2020)

Breaching the Delivery Barrier: Chemical and Physical Airway Epithelium Disruption Strategies for Enhancing Lentiviral-Mediated Gene Therapy
por: McCarron, Alexandra, et al.
Publicado: (2021)

An Improved Protocol for the Production of Lentiviral Vectors
por: Brown, Logan Y., et al.
Publicado: (2020)

Lentiviral Vector Bioprocessing
por: Perry, Christopher, et al.
Publicado: (2021)

Slow and steady moves the cell
por: LeBrasseur, Nicole
Publicado: (2002)

Driving DNA transposition by lentiviral protein transduction
por: Cai, Yujia, et al.
Publicado: (2014)

Large-scale production of lentiviral vector in a closed system hollow fiber bioreactor
por: Sheu, Jonathan, et al.
Publicado: (2015)

The Inside Out of Lentiviral Vectors
por: Durand, Stéphanie, et al.
Publicado: (2011)

Clinical use of lentiviral vectors
por: Milone, Michael C., et al.
Publicado: (2018)

Special Issue “Lentiviral Vectors”
por: Takeuchi, Yasuhiro
Publicado: (2022)

Scaling Up of Steric Exclusion Membrane Chromatography for Lentiviral Vector Purification
por: Labisch, Jennifer Julia, et al.
Publicado: (2023)

Alcohol and stroke: the splitters win again
por: Klatsky, Arthur L., et al.
Publicado: (2016)

Commentary: Let's just celebrate this win
por: Klapper, Jacob A.
Publicado: (2021)

Efficient gene targeting mediated by a lentiviral vector-associated meganuclease
por: Izmiryan, Araksya, et al.
Publicado: (2011)

Integrase-Defective Lentiviral Vector Is an Efficient Vaccine Platform for Cancer Immunotherapy
por: Morante, Valeria, et al.
Publicado: (2021)

Safe and efficient lentiviral vector integration with HSC-targeted gene therapy
por: Radtke, Stefan, et al.
Publicado: (2023)

Promoter Optimization Circumvents Bcl-2 Transgene-Mediated Suppression of Lentiviral Vector Production
por: Kok, Cindy Y., et al.
Publicado: (2023)

An optimized measles virus glycoprotein-pseudotyped lentiviral vector production system to promote efficient transduction of human primary B cells
por: Vamva, Eirini, et al.
Publicado: (2022)

A Win for Workforce Development: The Value of PH WINS for ASTHO Affiliates
por: Becker, Scott J., et al.
Publicado: (2019)

Development and Validation of the Win-Win Scale
por: Zhang, Shan, et al.
Publicado: (2021)

Slow but steady for NF-κB
por: Leslie, Mitch
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_4nmb2pih3jmeo4hhcm7csob7ia